With further rate cuts expected, low interest rates are here to stay – and income-oriented investors are increasingly turning to dividend-focused funds. However, when it comes to which dividend ETFs are the best, it’s not necessarily the ones with the highest yields. Today’s article highlights five dividend ETFs which have been identified as top picks by analysts taking into consideration “expense ratios, how the funds weigh certain stocks as well as technical factors such as tracking errors.” For these five top-rated dividend ETFs, CLICK HERE.
“Tech stocks can be fickle and volatile — but they can also experience rapid growth in short periods of time,” notes the author of today’s article, who identifies five “up and coming” companies in the technology sector that traders may want to consider keeping an eye on. For these five tech stocks to watch – including a designer and manufacturer of MRI equipment and a company whose stock has seen phenomenal growth (and numerous Buy ratings from analysts) – CLICK HERE.
“A surgeon needs a variety of instruments. Investors should use a variety of tools, too,” advises the author of today’s article, who proceeds to highlight a handful of stocks that appear attractive right now based on a tool that he believes individual investors underutilize: the price/cash flow ratio. “Cash flow,” he notes, “attempts to measure the actual money coursing through the arteries and veins of a business.” For these five stocks that may be worth considering based on price to cash flow, CLICK HERE.
In today’s article, the author – who has been investing for 40 years – distills all the knowledge he has acquired over the course of those years down into a few key lessons, reflecting strategies he believes can be applied in order “to navigate a course to outperformance”. For these three lessons – including the investing style he believes makes the most sense and how to be a “counter puncher” when it comes to the rise of computer based trading – CLICK HERE.
With growth in short supply, the author of today’s article focuses in on “a group of companies that [he] think[s] will benefit in the future as more investors look beyond large caps to find growth in other sectors.” More specifically, he screened for stocks priced under $10 with expected earnings growth of 20%+ over the next 3-5 years, and which are “already experiencing some momentum that is usually a catalyst for more gains ahead.” For the six stocks that passed this screen, CLICK HERE.
With the bull market in its 10th year, the stock market challenging all-time highs, and assorted economic and political concerns, investors may be considering rotating out of growth stocks and into value stocks – but the author of today’s article advises “value investors had better be very cautious about what sort of ‘value’ they are looking for”, noting that “they often ignore or overlook the signs that a value trap is just about to eat into their assets.” He proceeds to outline “11 specific areas that investors need to consider when it comes to value investing now that the stock market has again challenged new all-time highs.” For more, CLICK HERE.
“Making money on marijuana (cannabis with high content of intoxicating THC) and hemp (cannabis that contains low content of THC) will be extremely difficult — except perhaps in one specific area,” advises the author of today’s article, who outlines where he believes the real money in marijuana won’t be made (growers and pharmaceutical companies, to be exact) and that “one specific area” where he believes it will be made. For more, CLICK HERE.
A railroad operator, a Canadian bank, a global healthcare company with a focus on diabetes care, a tobacco company, and a biotech focused on treatments for unmet medical needs make up the five companies highlighted in today’s article as being undervalued and having grown their earnings per share over a five-year period, with the author noting that “Companies that are growing their earnings are often good investments because they can return a solid profit to investors.” For these five stocks that are attracting the interest of investing gurus, CLICK HERE.
A health care company whose shares are up 57% in the past year and which, unlike many other health care companies, is not threatened by the possibility of a “Medicare for All” type system (in fact, it could actually benefit from a national health insurance model) leads a selection of stocks that have risen sharply (50% or more) in the past 12 months and appear to have the potential for further gains. For these stocks that may be worthy of consideration, CLICK HERE.
The author of today’s article calls it “The F9 Problem”: checking your profit and loss (P&L) statement too often (or not often enough) and making poor decisions (or avoiding taking necessary action) as a result. However, based on a finding published a few weeks ago on Twitter, there may be a solution to this problem – a “sweet spot” for checking your P&L. What is it? CLICK HERE.